CN105944150B - 一种水凝胶和应用该水凝胶的人工皮肤及其制备方法 - Google Patents

一种水凝胶和应用该水凝胶的人工皮肤及其制备方法 Download PDF

Info

Publication number
CN105944150B
CN105944150B CN201610176983.3A CN201610176983A CN105944150B CN 105944150 B CN105944150 B CN 105944150B CN 201610176983 A CN201610176983 A CN 201610176983A CN 105944150 B CN105944150 B CN 105944150B
Authority
CN
China
Prior art keywords
hydrogel
skin
cortex
artificial skin
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610176983.3A
Other languages
English (en)
Other versions
CN105944150A (zh
Inventor
张洪波
殷瑞雪
陆益栋
路腾新
杨可
章文俊
沈丹艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Blackfire Medical Technology Co Ltd
East China University of Science and Technology
Original Assignee
Shanghai Blackfire Medical Technology Co Ltd
East China University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Blackfire Medical Technology Co Ltd, East China University of Science and Technology filed Critical Shanghai Blackfire Medical Technology Co Ltd
Priority to CN201610176983.3A priority Critical patent/CN105944150B/zh
Publication of CN105944150A publication Critical patent/CN105944150A/zh
Application granted granted Critical
Publication of CN105944150B publication Critical patent/CN105944150B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60Materials for use in artificial skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/26Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)

Abstract

本发明涉及一种水凝胶和应用该水凝胶的人工皮肤及其制备方法。所述水凝胶由前驱体和胶原水溶液混合后交联而成,所述前驱体为壳聚糖、酪氨酸酶及透明质酸的水溶液。本发明采用胶原、透明质酸及壳聚糖等天然高分子材料制成了适合于细胞生长及包裹细胞的水凝胶,同时利用酶预交联及三维打印成型后物理交联,实现具有分层的人工皮肤结构。获得的人工皮肤具有类似于人体皮肤的力学性能,可用于皮肤组织的修复与再生及皮肤类药物模型。

Description

一种水凝胶和应用该水凝胶的人工皮肤及其制备方法
技术领域
本发明涉及生物医用材料领域,尤其涉及一种水凝胶和应用该水凝胶的人工皮肤及其制备方法。
背景技术
皮肤是覆盖和保护体表的重要组织器官。由于炎症、溃疡、外伤、烧伤、手术等原因常造成皮肤的缺损和异常。对于这种组织缺损目前多采用自体皮肤移植的方法,这不仅造成供皮区新的创伤缺陷,而且经常受到供皮来源的限制。
随着组织工程技术的发展,制备人工皮肤已成为热点。理想的组织工程话皮肤能够模仿天然皮肤的结构,具有表皮层和真皮层的复合型皮肤。
为了解决皮肤缺损问题,美国已开发出数十种皮肤替代材料,包括有同种异体皮肤、异种皮肤、无细胞皮肤组织工程支架和人工合成材料皮肤。同种异体皮肤有AllopatchHDTM、AlloskinTM等十余种,无细胞组织工程支架包括有IntegraTM等多种皮肤替代材料,这些材料都存在免疫排斥火车需要再次制皮等问题。
我国在皮肤缺损治疗领域的发展较晚,经过近十年来的发展,有部分产品已上市,例如第四军医大学金岩教授开发的含人体表皮细胞合成纤维细胞的人工皮肤,也有部分产品进入开发应用阶段,例如,中国专利CN1485099A公开了一种人工皮肤的制备方法,制备一种含表皮层和真皮层的人工皮肤,但该皮肤存在表皮层和真皮层易于分离和无法耐受手术缝合的问题。中国专利CN101716376公开了一种生长因子缓释型双层人工皮肤,中国专利CN1785444公开了一种胶原-壳聚糖和硅橡胶双层皮肤再生支架及其制备方法,这些产品均存在表皮层与人工皮肤力学性能不匹配和需要二次植皮的问题。
因此,我们需要一种新的人工皮肤及其制备方法。
发明内容
本发明解决了上述问题,并且,本发明的一个目标是提供一种水凝胶,适合于细胞生长。本发明的另一个目标是提供一种利用所述水凝胶制备的人工皮肤。
为了实现上述目的,本发明一例示性实施例提供一种水凝胶,适合于细胞生长及包裹细胞。所述水凝胶由前驱体和胶原水溶液混合通过酶预交联和打印过程物理交联双交联发而成,其中,所述前驱体为壳聚糖、酪氨酸酶及透明质酸的水溶液;所述壳聚糖、酪氨酸酶及透明质酸的质量百分比浓度为:壳聚糖5~12%;酪氨酸酶3~9%;透明质酸3~10%。
在本发明一实施例中,所述胶原水溶液为将灭菌后的胶原以质量百分浓度为5~10%的浓度溶解于灭菌培养液后获得的混合溶液。
在本发明一实施例中,所述水凝胶在剪切率为10S-1时的黏度范围为10~100Pa·S。
本发明还提供一种人工皮肤,所述人工皮肤包含至少四层皮层,每一所述皮层均由上述水凝胶制成。
在本发明一实施例中,每一所述皮层的厚度为400微米。
本发明还提供一种上述人工皮肤的制备方法,包括以下步骤:S10、制备如权利要求1所述的水凝胶;S20、利用三维打印技术构建一皮层;S30、利用超声雾化戊二醛或N-羟基丁二酰亚胺溶液,用以对步骤S20构建的皮层进行交联;重复步骤S20和S30,获得多层分成人工皮肤。
在本发明一实施例中,所述步骤S10包括:S101、将壳聚糖、酪氨酸酶及透明质酸按照以下质量百分比浓度溶解于37℃的去离子水,其中,
壳聚糖 5~12%;
酪氨酸酶 3~9%;
透明质酸 3~10%;
S102、对步骤S101获得的溶液灭菌后获得前驱体;
S103、将胶原经乙醇熏蒸后灭菌,按照质量百分比浓度5~10%分散于灭菌培养液中,充分溶解;
S104、将步骤S103获得的混合液与步骤S102获得的前驱体混合,获得所述水凝胶。通过改变高分子浓度及交联剂浓度控制所述水凝胶的黏度。
在本发明一实施例中,在所述步骤S20中,控制每层皮层的尺寸为200~400微米,空隙率为0~60%。
在本发明一实施例中,在所述步骤S30中,所述戊二醛及N-羟基丁二酰亚胺溶液的质量百分比浓度为0.1~0.25%。
根据本发明的上述描述,本发明采用胶原、透明质酸及壳聚糖等天然高分子材料制成了适合于细胞生长及包裹细胞的水凝胶,同时利用酶预交联及三维打印成型后物理交联,实现具有分层的人工皮肤结构。获得的人工皮肤具有类似于人体皮肤的力学性能,可用于皮肤组织的修复与再生及皮肤类药物模型。
具体实施方式
以下,对本发明的一些示例性实施例进行描述。
实施例一、水凝胶及其制备
本实施例提供一种水凝胶及其制备方法。所述水凝胶适合于细胞生长及包裹细胞。所述由前驱体和胶原水溶液混合而成。制备方法为:首先,将壳聚糖、酪氨酸酶及透明质酸按照以下质量百分比浓度溶解于37℃的去离子水:5~12%的壳聚糖、3~9%的酪氨酸酶、3~10%的透明质酸,充分溶解后经滤菌器过滤除菌,获得前驱体;然后,将胶原经乙醇熏蒸后在紫外灯下照射24小时彻底灭菌,按照质量百分比浓度5~10%分散于灭菌培养液中,充分溶解;最后,将前驱体与胶原溶液混合,通过改变高分子浓度及交联剂浓度,控制所述水凝胶在剪切率为10S-1时的黏度范围为10~100Pa·S,获得所述水凝胶。
实施例二、人工皮肤及其制备
本实施例提供一种人工皮肤及其制备方法。所述人工皮肤包含至少四层,每一所述皮层均由实施例一制得的水凝胶制成,每一所述皮层的厚度为400微米。所述人工皮肤的制备方法具体包括以下步骤:
S101、将壳聚糖、酪氨酸酶及透明质酸按照以下质量百分比浓度溶解于37℃的去离子水,
壳聚糖 5~12%;
酪氨酸酶 3~9%;
透明质酸 3~10%;
S102、将步骤S101获得的溶液经滤菌器过滤除菌后获得前驱体;
S103、将胶原经乙醇熏蒸后在紫外灯下照射24小时彻底灭菌,按照质量百分比浓度5~10%分散于灭菌培养液中,充分溶解;
S104、将步骤S103获得的混合液与步骤S102获得的前驱体混合,通过改变高分子浓度、交联剂浓度控制所述水凝胶在剪切率为10S-1时的黏度范围为10~100Pa·S,获得所述水凝胶;
S20、利用三维打印技术构建一皮层,控制每层皮层的尺寸为200~400微米,空隙率为0~60%;
S30、利用超声雾化质量百分比浓度为0.1~0.25%的戊二醛或N-羟基丁二酰亚胺溶液,用以对步骤S20构建的皮层进行交联;重复步骤S20和S30,获得多层分成人工皮肤。
如上描述的,本发明采用胶原、透明质酸及壳聚糖等天然高分子材料制成了适合于细胞生长及包裹细胞的水凝胶,同时利用酶预交联及三维打印成型后物理交联,实现具有分层的人工皮肤结构。获得的人工皮肤具有类似于人体皮肤的力学性能,可用于皮肤组织的修复与再生及皮肤类药物模型。
尽管为了说明的目的而描述了本发明的一较佳实施例,本领域技术人员将理解的是,在不脱离如所附权利要求中公开的本发明的范围和精神下,多种修改、添加或替换是可行的。本发明的范围应在所附权利要求的基础上,以一种所述技术思路包含在与属于本发明的权利要求相当的范围内的方式进行解释。

Claims (7)

1.一种水凝胶,适合于细胞生长及包裹细胞,其特征在于,所述水凝胶由前驱体和胶原水溶液混合后通过酶预交联而成,其中,
所述前驱体为壳聚糖、酪氨酸酶及透明质酸的水溶液;所述壳聚糖、酪氨酸酶及透明质酸的质量百分比浓度为:
壳聚糖 5~12%;
酪氨酸酶 3~9%;
透明质酸 3~10%;
所述胶原水溶液为将灭菌后的胶原以质量百分浓度为5~10%的浓度溶解于灭菌培养液后获得的混合溶液;并且,所述水凝胶在剪切率为10S-1时的黏度范围为10~100Pa·S。
2.一种人工皮肤,其特征在于,所述人工皮肤包含至少四层皮层结构,每一所述皮层均由权利要求1所述的水凝胶制成。
3.如权利要求2所述的人工皮肤,其特征在于,每一所述皮层的厚度为400微米。
4.一种如权利要求2所述的人工皮肤的制备方法,其特征在于,包括以下步骤:S10、制备如权利要求1所述的水凝胶;S20、利用三维打印技术构建一皮层;S30、利用超声雾化戊二醛溶液或N-羟基丁二酰亚胺溶液,用以对步骤S20构建的皮层进行交联;重复步骤S20和S30,获得多层分成人工皮肤。
5.如权利要求4所述的制备方法,其特征在于,所述步骤S10包括:
S101、将壳聚糖、酪氨酸酶及透明质酸按照以下质量百分比浓度溶解于37℃的去离子水,
壳聚糖 5~12%;
酪氨酸酶 3~9%;
透明质酸 3~10%;
S102、对步骤S101获得的溶液灭菌后获得前驱体;
S103、将胶原经乙醇熏蒸后灭菌,按照质量百分比浓度5~10%分散于灭菌培养液中,充分溶解;
S104、将步骤S103获得的混合液与步骤S102获得的前驱体混合,获得所述水凝胶;所述水凝胶在剪切率为10S-1时的黏度范围为10~100Pa·S。
6.如权利要求4所述的制备方法,其特征在于,在所述步骤S20中,控制每层皮层的尺寸为200~400微米,空隙率为0~60%。
7.如权利要求4所述的制备方法,其特征在于,在所述步骤S30中,所述戊二醛溶液或N-羟基丁二酰亚胺溶液的质量百分比浓度为0.1~0.25%。
CN201610176983.3A 2016-03-25 2016-03-25 一种水凝胶和应用该水凝胶的人工皮肤及其制备方法 Active CN105944150B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610176983.3A CN105944150B (zh) 2016-03-25 2016-03-25 一种水凝胶和应用该水凝胶的人工皮肤及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610176983.3A CN105944150B (zh) 2016-03-25 2016-03-25 一种水凝胶和应用该水凝胶的人工皮肤及其制备方法

Publications (2)

Publication Number Publication Date
CN105944150A CN105944150A (zh) 2016-09-21
CN105944150B true CN105944150B (zh) 2019-05-10

Family

ID=56917337

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610176983.3A Active CN105944150B (zh) 2016-03-25 2016-03-25 一种水凝胶和应用该水凝胶的人工皮肤及其制备方法

Country Status (1)

Country Link
CN (1) CN105944150B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109996566A (zh) * 2016-10-18 2019-07-09 奥尔胡斯大学 打印的透明质酸支架
CN107261213A (zh) * 2017-06-13 2017-10-20 北京恒峰铭成生物科技有限公司 一种活性水凝胶及其制备方法和在手术创伤修复中的应用
CN113244437A (zh) * 2021-06-15 2021-08-13 福州大学 一种仿生多功能复合海绵敷料的制备方法与应用
CN113559314B (zh) * 2021-08-06 2022-05-27 西北大学 用于糖尿病足溃疡的仿细胞外基质水凝胶敷料及制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110208A (en) * 1995-04-27 2000-08-29 Fidia Advanced Biopolymers S.R.L Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives
CN1785444A (zh) * 2005-12-07 2006-06-14 浙江大学 胶原-壳聚糖和硅橡胶双层皮肤再生支架及其制备方法
CN103755981A (zh) * 2014-01-14 2014-04-30 西北大学 一种用作皮肤填充材料的水凝胶及其制备方法
CN104004231A (zh) * 2014-06-12 2014-08-27 东南大学 一种生物大分子互穿网络水凝胶及其制备方法
CN104984407A (zh) * 2015-07-01 2015-10-21 世科志扬(北京)医疗科技有限公司 一种组织工程人工皮肤及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008069760A1 (en) * 2006-12-05 2008-06-12 Nanyang Technological University Three-dimensional porous hybrid scaffold and manufacture thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110208A (en) * 1995-04-27 2000-08-29 Fidia Advanced Biopolymers S.R.L Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives
CN1785444A (zh) * 2005-12-07 2006-06-14 浙江大学 胶原-壳聚糖和硅橡胶双层皮肤再生支架及其制备方法
CN103755981A (zh) * 2014-01-14 2014-04-30 西北大学 一种用作皮肤填充材料的水凝胶及其制备方法
CN104004231A (zh) * 2014-06-12 2014-08-27 东南大学 一种生物大分子互穿网络水凝胶及其制备方法
CN104984407A (zh) * 2015-07-01 2015-10-21 世科志扬(北京)医疗科技有限公司 一种组织工程人工皮肤及其制备方法

Also Published As

Publication number Publication date
CN105944150A (zh) 2016-09-21

Similar Documents

Publication Publication Date Title
Kim et al. 4D-bioprinted silk hydrogels for tissue engineering
Vig et al. Advances in skin regeneration using tissue engineering
Kalirajan et al. A critical review on polymeric biomaterials for biomedical applications
Yahya et al. Insights into the role of biopolymer aerogel scaffolds in tissue engineering and regenerative medicine
Lee et al. Scaffold technologies for controlling cell behavior in tissue engineering
Tavakoli et al. Bioengineered skin substitutes: Advances and future trends
CN105944150B (zh) 一种水凝胶和应用该水凝胶的人工皮肤及其制备方法
Marga et al. Toward engineering functional organ modules by additive manufacturing
García-García et al. Histological, biomechanical, and biological properties of genipin-crosslinked decellularized peripheral nerves
Ortega et al. Combination of microstereolithography and electrospinning to produce membranes equipped with niches for corneal regeneration
JP6765540B2 (ja) 生着率を増加させた移植用真皮層及びその製造方法
Varoni et al. Hierarchic micro-patterned porous scaffolds via electrochemical replica-deposition enhance neo-vascularization
Anton-Sales et al. Bacterial nanocellulose and titania hybrids: cytocompatible and cryopreservable cell carriers
Alizadeh et al. Evaluating the effects of vacuum on the microstructure and biocompatibility of bovine decellularized pericardium
Ortuño-Lizarán et al. Influence of synthesis parameters on hyaluronic acid hydrogels intended as nerve conduits
Stocco et al. Bridging gaps in peripheral nerves: from current strategies to future perspectives in conduit design
Ríos-Galacho et al. An overview on the manufacturing of functional and mature cellular skin substitutes
Kokorev et al. Evaluation of allogenic hepato-tissue engineered in porous TiNi-based scaffolds for liver regeneration in a CCl4-induced cirrhosis rat model
Mensah et al. The chicken eggshell membrane: A versatile, sustainable, biological material for translational biomedical applications
Gregory et al. Additive manufacturing of polyhydroxyalkanoate-based blends using fused deposition modelling for the development of biomedical devices
Masri et al. Injectable crosslinked genipin hybrid gelatin–PVA hydrogels for future use as bioinks in expediting cutaneous healing capacity: physicochemical characterisation and cytotoxicity evaluation
Kumar Sahi et al. Silk-based biomaterials for designing bioinspired microarchitecture for various biomedical applications
Kopp et al. Production and characterization of porous fibroin scaffolds for regenerative medical application
CN111467570A (zh) 一种负载microRNA组织工程支架及其制备方法
Merotto et al. Three-Dimensional Bioprinting of Naturally Derived Hydrogels for the Production of Biomimetic Living Tissues: Benefits and Challenges

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20180208

Address after: 200237 Meilong Road, Shanghai, No. 130, No.

Applicant after: East China University of Science and Technology

Applicant after: Shanghai Blackfire Medical Technology Co Ltd

Address before: 200237 Meilong Road, Shanghai, No. 130, No.

Applicant before: East China University of Science and Technology

Applicant before: Black boat technology (Shanghai) Co., Ltd.

GR01 Patent grant
GR01 Patent grant